Simultaneous LCMSMS Method Buprenorphine and
Norbuprenorphine
Analyte
Lower Limit of Quantitation
(mg/L)
Acceptable Anticoagulants
Required PlasmaVolume
CV% low QC
Buprenorphine
0.000250
EDTA Plasma (K)
Minimal 1 mL*
10
Norbuprenorphine
0.000250
8.8
Samples are prepared by solid phase extraction prior to
chromatography. Deuterated internal standards are added to 0.5 mL of sample
mixed with HCL solution prior to application onto a preconditioned Waters
Oasis� MCX cartridge. The cartridge is rinsed with 5% methanol in 0.1N HCl. The
samples are then eluted with 1% ammonium hydroxide in methanol and evaporated
to dryness. The samples are reconstituted with a mix of mobile phase A and B.
Forty percent of the reconstituted samples are injected in the LCMSMS system.
Samples are analyzed on a Agilent
HPLC system coupled to a Sciex API3000 triple quadupole mass analyzer used in
the positive MRM mode. A gradient chromatography method separates the compounds
from other components on a Waters Symmetry� C18 column. Buprenorphine is
detected using MS/MS pair 468/396; NBUP is detected as the protonated species
only, 414.7.A slow collection of ions
at the detector allows for some gains in sensitivity.Each sample analysis requires 6 minutes.